These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

745 related items for PubMed ID: 19781383

  • 21. Transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma in cirrhotics: functional hepatic reserve and survival.
    Grieco A, Marcoccia S, Miele L, Marmiroli L, Caminiti G, Ragazzoni E, Cotroneo AR, Cefaro GA, Rapaccini GL, Gasbarrini G.
    Hepatogastroenterology; 2003; 50(49):207-12. PubMed ID: 12630024
    [Abstract] [Full Text] [Related]

  • 22. A case-control study comparing percutaneous radiofrequency ablation alone or combined with transcatheter arterial chemoembolization for hepatocellular carcinoma.
    Peng ZW, Chen MS, Liang HH, Gao HJ, Zhang YJ, Li JQ, Zhang YQ, Lau WY.
    Eur J Surg Oncol; 2010 Mar; 36(3):257-63. PubMed ID: 19643561
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study.
    Lee HS, Kim JS, Choi IJ, Chung JW, Park JH, Kim CY.
    Cancer; 1997 Jun 01; 79(11):2087-94. PubMed ID: 9179054
    [Abstract] [Full Text] [Related]

  • 28. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.
    Yoon SM, Lim YS, Won HJ, Kim JH, Kim KM, Lee HC, Chung YH, Lee YS, Lee SG, Park JH, Suh DJ.
    Int J Radiat Oncol Biol Phys; 2012 Apr 01; 82(5):2004-11. PubMed ID: 21621346
    [Abstract] [Full Text] [Related]

  • 29. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B, Yu J, Wang L, Li C, Zhou T, Zhai L, Xing L.
    Am J Clin Oncol; 2003 Aug 01; 26(4):e92-9. PubMed ID: 12902905
    [Abstract] [Full Text] [Related]

  • 30. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.
    Takayasu K, Arii S, Ikai I, Kudo M, Matsuyama Y, Kojiro M, Makuuchi M, Liver Cancer Study Group of Japan.
    AJR Am J Roentgenol; 2010 Mar 01; 194(3):830-7. PubMed ID: 20173167
    [Abstract] [Full Text] [Related]

  • 31. Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: a non-randomized comparative study.
    Xi T, Lai EC, Min AR, Shi LH, Wu D, Xue F, Wang K, Yan Z, Xia Y, Shen F, Lau WY, Wu MC.
    Hepatogastroenterology; 2012 Jun 01; 59(116):1198-203. PubMed ID: 22580673
    [Abstract] [Full Text] [Related]

  • 32. [Expression and prognostic value of proliferating cell nuclear antigen in hepatocellular carcinoma patients received preoperative transcatheter arterial chemoembolization].
    Guo RP, Yu WS, Wei W.
    Ai Zheng; 2008 Feb 01; 27(2):201-5. PubMed ID: 18279622
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Hepatocellular carcinoma invading the main portal vein: treatment with transcatheter arterial chemoembolization and portal vein stenting.
    Zhang XB, Wang JH, Yan ZP, Qian S, Liu R.
    Cardiovasc Intervent Radiol; 2009 Jan 01; 32(1):52-61. PubMed ID: 18931871
    [Abstract] [Full Text] [Related]

  • 35. Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma.
    Jang JW, Park YM, Bae SH, Choi JY, Yoon SK, Chang UI, Nam SW, Kim BS.
    Cancer Chemother Pharmacol; 2004 Nov 01; 54(5):415-20. PubMed ID: 15235823
    [Abstract] [Full Text] [Related]

  • 36. [A comparison of patients with hepatocellular carcinoma between a short-term (less than 6 months) survival group and a long-term (over 24 months) survival group after treatment with transcatheter arterial chemoembolization].
    Kang IK, Kim SW, Hahn SH, Cho SC, Gham CW, Lee DH.
    Taehan Kan Hakhoe Chi; 2002 Jun 01; 8(2):189-200. PubMed ID: 12499805
    [Abstract] [Full Text] [Related]

  • 37. Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma.
    Park JW, Koh YH, Kim HB, Kim HY, An S, Choi JI, Woo SM, Nam BH.
    J Hepatol; 2012 Jun 01; 56(6):1336-42. PubMed ID: 22314421
    [Abstract] [Full Text] [Related]

  • 38. Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation.
    Cabibbo G, Genco C, Di Marco V, Barbara M, Enea M, Parisi P, Brancatelli G, Romano P, Craxì A, Cammà C.
    Aliment Pharmacol Ther; 2011 Jul 01; 34(2):196-204. PubMed ID: 21564144
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.